Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
Trump approves South Korea's plan to build nuclear-powered submarines, raising concerns over proliferation and regional security.
Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
Trump approves South Korea's plan to build nuclear-powered submarines, raising concerns over proliferation and regional security.